Varian receives U.S. FDA clearance for its IntelliBlate microwave ablation system

image credit- shutterstock

Varian, a Siemens Healthineers company, announces receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its IntelliBlate microwave ablation system, intended for ablation of soft tissue. Designed to provide clinicians with greater predictability, precision, and control during their procedures, IntelliBlate serves as the cornerstone of a future-focused, integrated ecosystem for microwave ablation.

IntelliBlate produces large, controlled spherical ablation zones for predictable treatment delivery. With the option to utilize a single or dual probe – each with linked or independent controls – IntelliBlate delivers the versatility to meet the unique clinical needs of each patient. Precision and control are amplified by the Ximitry probe, which enables features such as Laser Disk Alignment and intuitive LED indicators.

The compact design and intuitive interface of IntelliBlate delivers a portable and flexible system that reduces barriers for this important treatment method. Modular elements provide the flexibility for clinicians to expand their treatment capabilities to meet changing clinical demands, while keeping control over operational efficiency throughout the ablation procedure.

With future plans to connect intelligent therapeutic technologies and image-guided innovations in a single platform, IntelliBlate aims to provide clinicians with even greater predictability of probe placement, treatment delivery, and procedural confirmation.